BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7588140)

  • 1. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Aug; 72(8):490-1. PubMed ID: 7588140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of hepatitis B surface antigen (HBsAg) among drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Mar; 72(3):198-9. PubMed ID: 7796776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.
    El Beltagy KE; Al Balawi IA; Almuneef M; Memish ZA
    Int J Infect Dis; 2008 Sep; 12(5):495-9. PubMed ID: 18400539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
    Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of the isolated anti-HBc carrier. A study of 1797 drug addicts. The Intersert Group of Scientific Collaboration].
    Mezzelani P; Quaglio G; Venturini L; Lugoboni F
    Recenti Prog Med; 1994 Sep; 85(9):419-24. PubMed ID: 7938872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B virus (HBV) in Italian adolescents.
    Di Ciommo V; Ferrario F; Spina G; La Spesa F; Rubino S
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):437-9. PubMed ID: 2152302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
    Panhotra BR; Al-Bahrani A; Ul-Hassan Z
    Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
    Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
    Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia.
    Al-Sebayel MI; Khalaf HA; Ramirez CG
    Saudi Med J; 2002 Mar; 23(3):298-300. PubMed ID: 11938420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of markers of hepatitis B in the adult German population.
    Jilg W; Hottenträger B; Weinberger K; Schlottmann K; Frick E; Holstege A; Schölmerich J; Palitzsch KD
    J Med Virol; 2001 Feb; 63(2):96-102. PubMed ID: 11170044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1997 Feb; 74(2):89-91. PubMed ID: 9185392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.